RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      Development of Molecularly Imprinted Membranes for Selective Determination of Urinary Ultra-Trace 5-Fluorouracil as Antineoplastic Drug Used in Chemotherapy

      한글로보기

      https://www.riss.kr/link?id=A106836738

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background: The incidence of neoplasm has significantly increased around the world over the last decades, resulting in use of anti-neoplastic drugs and the potential for occupational exposure to these drugs. One of the most commonly used chemotherapeu...

      Background: The incidence of neoplasm has significantly increased around the world over the last decades, resulting in use of anti-neoplastic drugs and the potential for occupational exposure to these drugs. One of the most commonly used chemotherapeutic drugs for treatment of malignancies is 5-fluorouracil (5-FU).
      Objectives: In this study, in order to develop an appropriate adsorbent for selective extraction of ultra-trace 5-fluorouracil from urine samples, molecularly imprinted membranes (MIMs) of 5-FU were prepared by encapsulating molecularly imprinted polymer nanoparticles (MIP-NPs) into the electrospun polyethylene terephthalate (PET) nanofibers. Methods: The MIP-NPs encapsulated into electrospun PET nanofibers were prepared by precipitation polymerization technique. These MIMs were used as selective sorbents for solid-phase extraction (SPE) of ultra-trace 5-FU from different samples prior to the analysis by high performance liquid chromatography (HPLC). Central Composite Design (CCD) was used for optimization of effective parameters in sorption and desorption steps of the molecularly imprinted membrane solid phase extraction (MIMSPE). Results: The optimum operating conditions for the proposed method were pH: 6.2, amount of sorbent: 10.3mg, and absorption time: 20.5h, the volume of eluent: 1 mL, the composition of elution solvent: the ratio of 90.3:9.7 methanol and acetic acid, and desorption time: 1.27 h. Under these optimized conditions, the limit of detection for 5-FU by MIMSPE was 0.07 μg L-1. The recoveries of 5-FU from urine sample ranged from 92.95±3.85 to 94.85±2.85%. Conclusion: The proposed MIMSPE-HPLC method can potentially be applied for selective detection of 5-FU in real samples with no special sample pretreatment steps.

      더보기

      참고문헌 (Reference)

      1 K. Wang, 9 : 970-, 1998

      2 H. Licea-Perez, 877 : 1040-, 2009

      3 J. E. Kosovec, 22 : 224-, 2008

      4 R. Pisano, 38 : 738-, 2005

      5 H. Ishii, 30 : 1882-, 2016

      6 R. M. Mader, 19 : 2981-, 1998

      7 E. A. De Bruijn, 14 : 627-, 1991

      8 J. R. Flores, 57 : 493-, 2003

      9 H. -J. Lu, 788 : 291-, 2003

      10 M. Forough, 1040 : 22-, 2017

      1 K. Wang, 9 : 970-, 1998

      2 H. Licea-Perez, 877 : 1040-, 2009

      3 J. E. Kosovec, 22 : 224-, 2008

      4 R. Pisano, 38 : 738-, 2005

      5 H. Ishii, 30 : 1882-, 2016

      6 R. M. Mader, 19 : 2981-, 1998

      7 E. A. De Bruijn, 14 : 627-, 1991

      8 J. R. Flores, 57 : 493-, 2003

      9 H. -J. Lu, 788 : 291-, 2003

      10 M. Forough, 1040 : 22-, 2017

      11 C. Jochheim, 217 : 285-, 1994

      12 M. Canal-Raffin, 1038 : 109-, 2016

      13 Z. Xu, 119 : 845-, 2010

      14 A. Afkhami, 175 : 69-, 2011

      15 A. Afkhami, 172 : 125-, 2011

      16 F. Omidi, 16 : 1131-, 2019

      17 F. Omidi, 10 : 4588-, 2018

      18 F. Omidi, 395 : 213-, 2015

      19 S. Wang, 32 : 1333-, 2009

      20 C. T. Elliott, 123 : 1103-, 1998

      21 V. B. Kandimalla, 380 : 587-, 2004

      22 C. Michailof, 1182 : 25-, 2008

      23 F. Omidi, 43 : 645-, 2014

      24 S. Wang, 55 : 3869-, 2007

      25 J. Ou, 1117 : 163-, 2006

      26 J. Ou, 69 : 1001-, 2006

      27 S. Song, 390 : 2141-, 2008

      28 F. Omidi, 12 : 137-, 2014

      29 F. Puoci, 93 : 349-, 2005

      30 C. Yu, 888 : 63-, 2000

      31 W. J. Kim, 7 : 4160-, 2011

      32 W. J. Kim, 65 : 1388-, 2011

      33 N. Bhardwaj, 28 : 325-, 2010

      34 P. Tonglairoum, 14 : 838-, 2013

      35 S. E. Diltemiz, 5 : 47-, 2016

      36 S. Kalantary, 1 : 1042-, 2019

      37 S. Kalantary, 9 : 24858-, 2019

      38 B. Zaarour, 89 : 2406-, 2019

      39 L. Zhu, 17 : 410-, 2019

      40 M. Z. Ongun, 90 : 177-, 2012

      41 N. Charernsriwilaiwat, 427 : 379-, 2012

      42 B. Zaarour, 136 : 47049-, 2019

      43 B. Zaarour, 17 : 181-, 2019

      44 B. Zaarour, 8 : 42353-, 2018

      45 T. H. Connor, 56 : 354-, 2006

      46 C. -Y. Hon, 2 : 273-, 2011

      47 J. Usawanuwat, 1 : 72-, 2014

      48 M. Broto, 93 : 152-, 2017

      49 K. Falck, 1 : 1250-, 1979

      50 S. Krstev, 94 : 432-, 2003

      51 G. Dranitsaris, 11 : 69-, 2005

      52 W. Fransman, 112 : 2007

      53 T. H. Connor, 56 : 901-, 2014

      54 M. A. Ritchie, 7 : 51-, 2000

      55 F. Casale, 50 : 173-, 2004

      56 J. D. Potter, 91 : 916-, 1999

      57 G. Micoli, 750 : 25-, 2001

      58 Y. Krishnaiah, 16 : 185-, 2002

      59 R. L. Schilsky, 12 : 13-, 1998

      60 R. Turci, 789 : 169-, 2003

      61 P. Daumar, 46 : 2867-, 2011

      62 O. T. Fahmy, 34 : 1099-, 2004

      63 P. Compagnon, 677 : 380-, 1996

      64 M. Barberi-Heyob, 573 : 247-, 1992

      65 G. Fabrizi, 30 : 1297-, 2016

      66 B. Zaarour, 13 : 285-, 2018

      67 K. Yoshimatsu, 23 : 1208-, 2008

      68 E. Gracia-Lor, 1217 : 622-, 2010

      69 Y. -T. Wu, 164 : 527-, 2014

      70 G. Cirillo, 17 : 72-, 2009

      71 L. Li, 2 : 266-, 2012

      72 E. A. Dil, 39 : 9407-, 2015

      73 M. Ghaedi, 15 : 2974-, 2015

      74 M. Kolaei, 33 : 240-, 2016

      75 M. Khadem, 7 : 9-, 2017

      76 A. Asfaram, 5 : 72300-, 2015

      77 I. A. Alsarra, 804 : 435-, 2004

      78 G. E. Burroughs, "Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings"

      79 D. S. Shewach, "Introduction to Cancer Chemotherapeutics" ACS Publications 2009

      80 Bilal Zaarour, "A review on piezoelectric fibers and nanowires for energy harvesting" SAGE Publications 152808371987019-, 2019

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2012-06-04 학술지명변경 외국어명 : 미등록 -> Macromolecular Research KCI등재
      2008-01-01 평가 SCI 등재 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-07-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.4 0.33 0.97
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.75 0.62 0.296 0.21
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼